Harbin Pharmaceutical Group Co., Ltd.

¥5.55As of Sun 8 Nov 2026, 12:00 UTC
SSE:600664Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (3.45%)
Div yield —
ROE 10.02%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.19
PE TTM 22.46
TSR TTM 51.64%
Mkt cap ¥13.98B
ROIC 13.42%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥6.77
21.95%
(55.34%)
Hold 12|0|7|1|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.06
0.07
0.07
0.08
30.54%
26.99%
25.05%
26.76%
Revenue¥M
862.4
891.1
906.0
945.1
7.61%
5.09%
8.99%
8.30%
Peers (US$2.095B)
Cap (US$)
PE
2.143B
114.8x
2.081B
24.09x
2.100B
27.85x
Capital
TTM
5Y
10Y
Leveragex
0.335
(0.064)
(0.053)
EBIT/Intx
0.819
0.094
0.095
Own earn%
(68.66)
(42.44)
(32.52)
Sh yield%
44.63
57.73
55.42
Owners
Insiders/Inst%
6.27
61.32
Short interest%
1.22
SBC / revenue%
5.52
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
27–32
$1 testx
−0.1
Incr. ROIC%
5